Literature DB >> 28696242

Pseudomonas aeruginosa Clinical Isolates in Nepal Coproducing Metallo-β-Lactamases and 16S rRNA Methyltransferases.

Tatsuya Tada1,2, Kayo Shimada3, Kazuhito Satou4, Takashi Hirano4,5, Bharat M Pokhrel6, Jeevan B Sherchand6, Teruo Kirikae3,2.   

Abstract

A total of 11 multidrug-resistant Pseudomonas aeruginosa clinical isolates were obtained in Nepal. Four of these isolates harbored genes encoding one or more carbapenemases (DIM-1, NDM-1, and/or VIM-2), and five harbored genes encoding a 16S rRNA methyltransferase (RmtB4 or RmtF2). A novel RmtF variant, RmtF2, had a substitution (K65E) compared with the same gene in RmtF. To our knowledge, this is the first report describing carbapenemase- and 16S rRNA methyltransferase-coproducing P. aeruginosa clinical isolates in Nepal.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  16S rRNA methylase; Pseudomonas aeruginosa; carbapenemase; multidrug resistance

Mesh:

Substances:

Year:  2017        PMID: 28696242      PMCID: PMC5571325          DOI: 10.1128/AAC.00694-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides.

Authors:  Jun-Ichi Wachino; Kunikazu Yamane; Keigo Shibayama; Hiroshi Kurokawa; Naohiro Shibata; Satowa Suzuki; Yohei Doi; Kouji Kimura; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Dissemination of multidrug-resistant Klebsiella pneumoniae clinical isolates with various combinations of carbapenemases (NDM-1 and OXA-72) and 16S rRNA methylases (ArmA, RmtC and RmtF) in Nepal.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Rajan K Dahal; Shyam K Mishra; Hiroshi Ohara; Kayo Shimada; Teruo Kirikae; Bharat M Pokhrel
Journal:  Int J Antimicrob Agents       Date:  2013-08-24       Impact factor: 5.283

3.  Novel 16S rRNA methyltransferase RmtH produced by Klebsiella pneumoniae associated with war-related trauma.

Authors:  Jessica A O'Hara; Patrick McGann; Erik C Snesrud; Robert J Clifford; Paige E Waterman; Emil P Lesho; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

4.  Coproduction of 16S rRNA methyltransferase RmtD or RmtG with KPC-2 and CTX-M group extended-spectrum β-lactamases in Klebsiella pneumoniae.

Authors:  Maria Fernanda C Bueno; Gabriela R Francisco; Jessica A O'Hara; Doroti de Oliveira Garcia; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

5.  SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate.

Authors:  Jun-ichi Wachino; Hiroyuki Yoshida; Kunikazu Yamane; Satowa Suzuki; Mari Matsui; Takuya Yamagishi; Atsuko Tsutsui; Toshifumi Konda; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

6.  Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK.

Authors:  Laura Hidalgo; Katie L Hopkins; Belen Gutierrez; Cristina M Ovejero; Suruchi Shukla; Stephen Douthwaite; Kashi N Prasad; Neil Woodford; Bruno Gonzalez-Zorn
Journal:  J Antimicrob Chemother       Date:  2013-04-11       Impact factor: 5.790

7.  Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan.

Authors:  Teruo Kirikae; Yukie Mizuguchi; Yoshichika Arakawa
Journal:  J Antimicrob Chemother       Date:  2008-01-31       Impact factor: 5.790

Review 8.  The increasing threat of Pseudomonas aeruginosa high-risk clones.

Authors:  Antonio Oliver; Xavier Mulet; Carla López-Causapé; Carlos Juan
Journal:  Drug Resist Updat       Date:  2015-08-10       Impact factor: 18.500

9.  A Carbapenem-Resistant Pseudomonas aeruginosa Isolate Harboring Two Copies of blaIMP-34 Encoding a Metallo-β-Lactamase.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Akino Shiroma; Kazuma Nakano; Kuniko Teruya; Kazuhito Satou; Takashi Hirano; Masahiro Shimojima; Teruo Kirikae
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

10.  RmtC and RmtF 16S rRNA Methyltransferase in NDM-1-Producing Pseudomonas aeruginosa.

Authors:  Mohibur Rahman; Kashi Nath Prasad; Ashutosh Pathak; Binod Kumar Pati; Avinash Singh; Cristina M Ovejero; Saheem Ahmad; Bruno Gonzalez-Zorn
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

View more
  5 in total

1.  A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species.

Authors:  Kohei Uechi; Tatsuya Tada; Kayo Shimada; Kyoko Kuwahara-Arai; Momoko Arakaki; Takaaki Tome; Isamu Nakasone; Shiro Maeda; Teruo Kirikae; Jiro Fujita
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

2.  Acquisition of class C β-lactamase PAC-1 by ST664 strains of Pseudomonas aeruginosa.

Authors:  Maxime Bour; Damien Fournier; Thomas Jové; Armelle Pouzol; Guillaume Miltgen; Frédéric Janvier; Katy Jeannot; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

Review 3.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

4.  A novel high-resolution melting analysis approach for rapid detection of vancomycin-resistant enterococci.

Authors:  Hani Adnan Ozbak
Journal:  Ann Saudi Med       Date:  2018 May-Jun       Impact factor: 1.526

Review 5.  Research Updates of Plasmid-Mediated Aminoglycoside Resistance 16S rRNA Methyltransferase.

Authors:  Weiwei Yang; Fupin Hu
Journal:  Antibiotics (Basel)       Date:  2022-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.